22157.jpg
Myasthenia Gravis (MG) Market Analysis & Forecast to 2032: Global Opportunity Assessment, Epidemiology, Clinical Trials, Unmet Needs, Key Players
24 janv. 2024 03h43 HE | Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Myasthenia Gravis Market Opportunity Assessment, Epidemiology, Clinical Trials, Unmet Needs and Forecast to 2032" report has been added to ...
Global Myasthenia Gravis Treatment Market
Global Myasthenia Gravis Treatment Market Forecast and Trends 2023-2028, Featuring Profiles of AbbVie, Bausch Health, Gilead Sciences, Merck, Servier and Teva
18 déc. 2023 06h43 HE | Research and Markets
Dublin, Dec. 18, 2023 (GLOBE NEWSWIRE) -- The "Global Myasthenia Gravis Treatment Market: Forecast and Trends" report has been added to ResearchAndMarkets.com's offering. The global market for...
Logo.png
Myasthenia Gravis Market is Projected to Boost at a Moderate Growth Rate by 2032, Estimates DelveInsight | Leading Companies - DAS-MG, Catalyst, Cabaletta Bio, Janssen, Argenx, UCB Pharma, Alexion, Immunovant
25 oct. 2023 13h00 HE | DelveInsight Business Research LLP
New York, USA, Oct. 25, 2023 (GLOBE NEWSWIRE) -- Myasthenia Gravis Market is Projected to Boost at a Moderate Growth Rate by 2032, Estimates DelveInsight | Leading Companies - DAS-MG, Catalyst,...
AMR Logo.png
Myasthenia Gravis Treatment Market to Reach $3.1 Billion, Globally, by 2032 at 6.5% CAGR: Allied Market Research
15 mai 2023 21h00 HE | Allied Market Research
Portland, OR, May 15, 2023 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, "Myasthenia Gravis Treatment Market by Drug class (Monoclonal antibodies, Intravenous...
22157.jpg
Outlook on the Myasthenia Gravis Diagnosis and Treatment Global Market to 2028 - Featuring Avadel Pharmaceuticals, Bausch Health Companies, Baxter International and CSL Behring Among Others
05 janv. 2023 06h58 HE | Research and Markets
Dublin, Jan. 05, 2023 (GLOBE NEWSWIRE) -- The "Global Myasthenia Gravis Diagnosis and Treatment Market Forecast, 2022-2028" report has been added to ResearchAndMarkets.com's offering. The global...
MicrosoftTeams-image (5).png
Myasthenia Gravis Market to Reach US$ 2.4 Bn by 2027, TMR Report
28 juil. 2022 13h30 HE | Transparency Market Research
Wilmington, Delaware, United States, July 28, 2022 (GLOBE NEWSWIRE) -- Transparency Market Research Inc.: Analysts at TMR estimate the myasthenia gravis market to clip a CAGR of 8% during the...
Zion Market Research.jpg
Global Myasthenia Gravis Market Will Reach USD 2,091 Million By 2025: Zion Market Research
19 mars 2019 09h07 HE | Zion Market Research
New York, NY, March 19, 2019 (GLOBE NEWSWIRE) -- Zion Market Research has published a new report titled “Myasthenia Gravis Market by Diagnosis (Edrophonium Tests, Blood Tests, Pulmonary Function...
Transparency Market Research.jpg
Myasthenia Gravis Market to become worth US$2,313.1 mn by 2025, Says TMR
18 juin 2018 05h53 HE | Transparency Market Research
Albany, NY, June 18, 2018 (GLOBE NEWSWIRE) -- According to a research report by Transparency Market Research (TMR), the global myasthenia gravis market is expected to expand at a steady CAGR of...